Startseite Medizin Assessment of human cartilage glycoprotein 39 (YKL-40), preptin, and nitric oxide in adolescent patients with type 1 diabetes and its relation to cardiorenal affection
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Assessment of human cartilage glycoprotein 39 (YKL-40), preptin, and nitric oxide in adolescent patients with type 1 diabetes and its relation to cardiorenal affection

  • Soha M. Abd El Dayem EMAIL logo , Ahmed A. Battah , Amal El Shehaby und Nagwa Abd Allah
Veröffentlicht/Copyright: 21. Februar 2015

Abstract

Aim: To evaluate new biomarkers such as YKL-40, preptin, and nitric oxide (NO) in patients with diabetes and to assess its relation to cardiorenal injury.

Patients and methods: The study included 62 patients with type 1 diabetes and 30 healthy volunteers. Blood sample was taken for assessment of glycosylated hemoglobin, lipid profile, YKL-40, preptin, and NO. Also, urine sample was taken for analysis of albumin/creatinine ratio. Echocardiography was also done.

Results: NO was lower, whereas YKL-40, preptin, and albumin/creatinine ratio were significantly higher in patients with diabetes. NO had a significant negative correlation with LVEDD, LVESD, PWT, LV mass, YKL-40, preptin, and albumin/creatinine ratio. YKL-40 had a significant positive correlation with waist/height ratio, preptin and negative correlation with E/A ratio. Stepwise multiple regression revealed that E/A ratio is the only parameter related to YKL-40. On the contrary, NO and systolic blood pressure are related to preptin.

Conclusion: A significant reduction of NO and elevation of YKL-40 and preptin was found in patients with diabetes. A decrease in NO is associated with diastolic dysfunction, LV hypertrophy, and renal impairment, whereas YKL-40 is associated with diastolic dysfunction. An increase in preptin level was associated with hypertension.


Corresponding author: Soha M. Abd El Dayem, Professor of Pediatrics, Consultant of Diabetes and Endocrinology, Medical Research Division, Pediatrics Department, National Research Centre, Cairo, Egypt, Phone: +2 0106716852, Fax: +337093, E-mail:

References

1. Rathcke CN, Persson F, Tarnow L, Rossing P, Vestergaard H. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria. Diabetes Care 2009;32:323–28.10.2337/dc08-1144Suche in Google Scholar PubMed PubMed Central

2. Rathcke CN, Vestergaard H. YKL-40, a new inflammatory marker with relation to insulin resistance and with a role in endothelial dysfunction and atherosclerosis. Inflamm Res 2006;55:221–73.10.1007/s00011-006-0076-ySuche in Google Scholar PubMed

3. Millis AJ, Hoyle M, Kent L. In vitro expression of a 38,000 dalton heparin-binding glycoprotein by morphologically differentiated smooth muscle cells. J Cell Physiol 1986;127:366–72.10.1002/jcp.1041270304Suche in Google Scholar PubMed

4. Malinda KM, Ponce L, Kleinman HK, Shackelton LM, Millis AJ. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells. Exp Cell Res 1999;250:168–73.10.1006/excr.1999.4511Suche in Google Scholar PubMed

5. Shackelton LM, Mann DM, Millis AJ. Identification of a 38-kDa heparin-binding glycoprotein (gp38k) in differentiating vascular smooth muscle cells as a member of a group of proteins associated with tissue remodeling. J Biol Chem 1995;270:13076–83.10.1074/jbc.270.22.13076Suche in Google Scholar PubMed

6. Baykus Y, Gurates B, Aydin S, Celik H, Kavak B, et al. Changes in serum obestatin, preptin and ghrelins in patients with gestational diabetes mellitus. Clin Biochem 2012;45:198–202.10.1016/j.clinbiochem.2011.08.1131Suche in Google Scholar PubMed

7. Egido EM, Hernandez R, Marco J, Silvestre RA. Effect of obestatin on insulin, glucagon and somatostatin secretion in the perfused rat pancreas. Regul Pept 2009;152:61–6.10.1016/j.regpep.2008.08.003Suche in Google Scholar PubMed

8. Buchanan CM, Phillips AR, Cooper GJ. Preptin derived from proinsulin-like growth factor II (proIGF-II) is secreted from pancreatic islet beta-cells and enhances insulin secretion. Biochem J 2007;360:431–39.10.1042/bj3600431Suche in Google Scholar

9. Yang G, Li L, Chen W, Boden G, Li K. Circulating preptin levels in normal, impaired glucose tolerance, and type 2 diabetic subjects. Ann Med 2009;41:52–6.10.1080/07853890802244142Suche in Google Scholar PubMed

10. Toda N, Takeshi Imamura T, Okamura T. Alteration of nitric oxide-mediated blood flow regulation in diabetes mellitus. Pharmacol Ther 2010;127:189–209.10.1016/j.pharmthera.2010.04.009Suche in Google Scholar PubMed

11. Creager MA, Cooke JP, Mendelsohn ME, Gallagher SJ, Coleman SM, et al. Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest 1990;86:228–34.10.1172/JCI114688Suche in Google Scholar

12. Calles-Escandon J, Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 2001;22:36–52.10.1210/edrv.22.1.0417Suche in Google Scholar

13. Cosentino F, Lüscher TF. Effects of blood pressure and glucose on endothelial function. Curr Hypertens Rep 2001;3:79–88.10.1007/s11906-001-0085-8Suche in Google Scholar

14. Tanner JM, Hiernaux J, Jarman S. Growth and physical studies. In: Weiner JS, Lourie JA, editors. Human biology: a guide to field methods. Oxford: Blackwell Scientific Publications, 1969:3–41.Suche in Google Scholar

15. Cameron N. The methods of auxological anthropology. In: Falkner F, Tanner JM, editors. Human growth 3 methodology. New York: Plenum Press, 1986:3–46.Suche in Google Scholar

16. Pettersen MD, Du W, Skeens ME, Humes RA. Regression equations for calculation of z scores of cardiac structures in a large cohort of healthy infants, children, and adolescents: an echocardiographic study. J Am Soc Echocardiogr 2008;21:922–34.10.1016/j.echo.2008.02.006Suche in Google Scholar

17. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986;57:450–58.10.1016/0002-9149(86)90771-XSuche in Google Scholar

18. Cori AD, Di BV, Miccoli R, Talini E, Palagi C, et al. Left ventricular function in normotensive young adults with well controlled type 1 diabetes mellitus. Am J Cardiol 2007;99:84–90.10.1016/j.amjcard.2006.07.063Suche in Google Scholar PubMed

19. Palmieri V, Capaldo B, Russo C, Laccarino M, Pezzullo S, et al. Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluation. Diabetes Res Clin Pract 2008;79:262–68.10.1016/j.diabres.2007.09.014Suche in Google Scholar PubMed

20. Abd El Dayem SM, Battah AA. Effect of glycemic control on the progress of left ventricular hypertrophy and diastolic dysfunction in children with type I diabetes mellitus. Anadolu Kardiyol Derg 2012;12:498–507.Suche in Google Scholar

21. Schalkwijk CG, Stehouwer CD. Vascular complications in diabetes mellitus: the role of endothelial dysfunction. Clin Sci (Lond) 2005;109:143–59.10.1042/CS20050025Suche in Google Scholar PubMed

22. Schram MT, Chaturvedi N, Schalkwijk CG, Fuller JH, Stehouwer CD, et al. Markers of inflammation is cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia 2005;48:370–78.10.1007/s00125-004-1628-8Suche in Google Scholar PubMed

23. Astrup AS, Tarnow L, Pietraszek L, Schalkwijk CG, Stehouwer CD, et al. Markers of endothelial dysfunction and inflammation in type 1 diabetic patients with or without diabetic nephropathy followed for 10 years: association with mortality and decline of glomerular filtration rate. Diabetes Care 2008;31:1170–76.10.2337/dc07-1960Suche in Google Scholar PubMed

24. Rathcke CN, Johansen JS, Vestergaard H. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance. Inflamm Res 2006;55:53–59.10.1007/s00011-005-0010-8Suche in Google Scholar PubMed

25. Rathcke CN, Raymond I, Kistorp C, Hildebrandt P, Faber J, et al. Low grade inflammation as measured by levels of YKL-40: association with an increased overall and cardiovascular mortality rate in an elderly population. Int J Cardiol 2010;143: 35–42.10.1016/j.ijcard.2009.01.043Suche in Google Scholar PubMed

26. Hempen M, Kopp HP, Elhenicky M, Hobaus C, Brix JM, et al. YKL-40 is elevated in morbidly obese patients and declines after weight loss. Obes Surg 2009;19:1557–63.10.1007/s11695-009-9917-4Suche in Google Scholar PubMed

27. Nielsen AR, Erikstrup C, Johansen JS, Fischer CP, Plomgaard P, et al. Plasma YKL-40: a BMI-independent marker of type 2 diabetes. Diabetes 2008;57:3078–82.10.2337/db08-0182Suche in Google Scholar PubMed PubMed Central

28. Rathcke CN, Vestergaard H. YKL-40 – an emerging biomarker in cardiovascular disease and diabetes. Cardiovasc Diabetol 2009;8:61.10.1186/1475-2840-8-61Suche in Google Scholar PubMed PubMed Central

29. Johansen JS. Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer. Dan Med Bull 2006;53:172–209.Suche in Google Scholar

30. Aydin S. Discovery of ghrelin hormone: research and clinical applications. Turk J Biochem 2007;32:76–89.Suche in Google Scholar

31. Aslan M, Celik O, Karsavuran N, Celik N, Dogan DG, et al. Maternal serum and cord blood preptin levels in gestational diabetes mellitus. J Perinatol 2011;31:350–55.10.1038/jp.2010.125Suche in Google Scholar PubMed

32. Sibal L, Agarwal SC, Schwedhelm E, Lüneburg N, Böger RH, et al. A study of endothelial function and circulating asymmetric dimethylarginine levels in people with type 1 diabetes without macrovascular disease or microalbuminuria. Cardiovasc Diabetol 2009;8:27, Published online 2009 June 1.10.1186/1475-2840-8-27Suche in Google Scholar PubMed PubMed Central

33. Altinova AE, Arslan M, Sepici-Dincel A, Akturk M, Altan N, et al. Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations. J Clin Endocrinol Metabol 2007;92:1881–85.10.1210/jc.2006-2643Suche in Google Scholar PubMed

34. Cavusoglu E, Ruwende C, Chopra V, Poludasu S, Yanamadala S, et al. Relation of baseline plasma ADMA levels to cardiovascular morbidity and mortality at two years in men with diabetes mellitus referred for coronary angiography. Atherosclerosis 2010;210:226–31.10.1016/j.atherosclerosis.2009.10.034Suche in Google Scholar PubMed

Received: 2014-8-24
Accepted: 2015-1-8
Published Online: 2015-2-21
Published in Print: 2015-3-1

©2015 by De Gruyter

Artikel in diesem Heft

  1. Frontmatter
  2. Highlight: Diabetes
  3. Diabetes mellitus in children and adolescents – a global epidemic which has become neglected
  4. Maturity-onset diabetes of the young (MODY): an update
  5. Relationship of plasma level of chemerin and vaspin to early atherosclerotic changes and cardiac autonomic neuropathy in adolescent type 1 diabetic patients
  6. How does autoimmune thyroiditis in children with type 1 diabetes mellitus influence glycemic control, lipid profile and thyroid volume?
  7. Profile of mood states in adult type 1 diabetes mellitus men and women with disease onset in childhood and in adulthood
  8. Evaluation of fetuin-A and carotid intima-media thickness in adolescent type 1 diabetic patients
  9. An increasing incidence of type 1 diabetes mellitus in Romanian children aged 0 to 17 years
  10. Resistin and right ventricular function in children with recently diagnosed type-1 diabetes mellitus: a case control study
  11. Assessment of human cartilage glycoprotein 39 (YKL-40), preptin, and nitric oxide in adolescent patients with type 1 diabetes and its relation to cardiorenal affection
  12. The effect of a home-based strength training program on type 2 diabetes risk in obese Latino boys
  13. From cerebral salt wasting to diabetes insipidus with adipsia: case report of a child with craniopharyngioma
  14. Three years of liraglutide treatment offers continuously optimal glycemic control in a pediatric patient with maturity-onset diabetes of the young type 3
  15. Diabetic euglycemic ketoacidosis in newly diagnosed type 1 diabetes mellitus during Ramadan fasting
  16. Transient neonatal hyperinsulinism with adaptation disorders: a report of three cases
  17. Acute mononeuropathy in a child with newly diagnosed type 1 diabetes mellitus
  18. Alternating hypoglycemia and hyperglycemia in a toddler with a homozygous p.R1419H ABCC8 mutation: an unusual clinical picture
  19. Cognitive functioning, metabolic control, and treatment type in youth with type 1 diabetes
  20. Images in pediatric endocrinology
  21. Benefit of testosterone in pediatric genital trauma
  22. Original articles
  23. Attenuated salivary cortisol response after exercise test in children with asthma
  24. Reliability of pubertal maturation self-assessment in a school-based survey
  25. Detection of inborn errors of metabolism using GC-MS: over 3 years of experience in southern China
  26. Assessing biological maturity: chronological age and the pubertal development scale predict free testosterone in adolescent males
  27. Evaluation of puberty by verifying spontaneous and stimulated gonadotropin values in girls
  28. Longitudinal changes in C-reactive protein, proform of eosinophil major basic protein, and pregnancy-associated plasma protein-A during weight changes in obese children
  29. Caries in adolescents in relation to their skeletal status
  30. Endothelial and metabolic disorders in adolescence: low birth weight is not an isolated risk factor
  31. Comparison of cortisol samples in the first two weeks of life in preterm infants
  32. Mutations in BTD gene causing biotinidase deficiency: a regional report
  33. Patient reports
  34. Late-onset hypercalcemia in Williams-Beuren syndrome: importance of early and frequent screening and intervention
  35. Hepatoblastoma presenting as precocious puberty: a case report
  36. Three cases of Wolfram syndrome with different clinical aspects
  37. L-asparaginase induced hypoglycemia in a case of acute lymphoblastic leukemia: a patient report
  38. Pyogenic granuloma, an unusual presentation of peripubertal vaginal bleeding. Case report and review of the literature
  39. Octreotide-associated cholestasis and hepatitis in an infant with congenital hyperinsulinism
  40. Two novel mutations in the homogentisate-1,2-dioxygenase gene identified in Chinese Han Child with Alkaptonuria
  41. Pituitary abscess in an adolescent girl: a case report and review of the literature
  42. Neonatal thyrotoxicosis with severe supraventricular tachycardia: case report and review of the literature
  43. Consumptive hypothyroidism associated with parotid infantile hemangioma
  44. Novel mutations in the SLC25A13 gene in a patient with NICCD and severe manifestations
  45. Short communications
  46. Tetrahydrobiopterin deficiency among Serbian patients presenting with hyperphenylalaninemia
Heruntergeladen am 19.12.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2014-0359/pdf
Button zum nach oben scrollen